Archives SFN 2010 Press Release: Validation of Extracellular Tau Oligomer Target November 16, 2010 By vera This article is sourced from an external publication. Read the original → ← PreviousOligomerix Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer’s DiseaseNext →Oligomerix, Inc. Completes $2 Million Series A Financing
